Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A PHASE I/II INSTITUTIONAL STUDY OF INTRAVESICAL TAXOL (PACLITAXEL) INSTILLATION FOR THE TREATMENT OF SUPERFICIAL BLADDER CANCER

NCT00002917 is registered in ClinicalTrials.gov with Mary Babb Randolph Cancer Center at West Virginia University Hospitals as lead sponsor.

NCT NCT00002917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A PHASE I/II INSTITUTIONAL STUDY OF INTRAVESICAL TAXOL (PACLITAXEL) INSTILLATION FOR THE TREATMENT OF SUPERFICIAL BLADDER CANCER
Lead sponsor
Mary Babb Randolph Cancer Center at West Virginia University Hospitals
Phase
Phase 1/2
Overall status
Completed
Start date
November 30, 1996
Completion date
May 31, 2004
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer